首页|期刊导航|中国实用外科杂志|动脉预阻断技术在局部进展期胰腺癌手术中应用

动脉预阻断技术在局部进展期胰腺癌手术中应用OA

Application of arterial prophylactic occlusion technique in surgery for locally advanced pancreatic cancer

中文摘要英文摘要

局部进展期胰腺癌(LAPC)约占初诊胰腺癌病例的30%,动脉系统受累是其实现根治性切除的核心技术瓶颈.近年来,新辅助治疗取得长足进步,越来越多的LAPC病人获得转化切除的机会;然而,转化治疗后手术仍常面临肿瘤与重要动脉壁致密粘连的严峻挑战.动脉鞘剥除技术通过沿动脉外膜与外弹力膜之间的解剖间隙进行精细剥离,可在不切除动脉的前提下实现R0切除,目前已成为动脉受累LAPC外科处理的首选策略之一.在此基础上,动脉预阻断技术(APOT)通过术中临时分级控制受累动脉血流,有效提升了动脉鞘剥除技术的安全阈值.APOT适用于新辅助治疗后动脉鞘剥除技术中,通过分级临时阻断血流,可缩短手术时间、减少出血,R0切除率达85.7%且不增加术后并发症的发生风险.

Locally advanced pancreatic cancer(LAPC)accounts for approximately 30%of newly diagnosed pancreatic cancer cases,with arterial involvement representing the foremost surgical barrier to curative resection.The recent progress in neoadjuvant therapy has rendered an increasing subset of these patients eligible for conversion surgery;nevertheless,the post-conversion procedure frequently remains encumbered by dense tumor adherence to major arterial walls.Arterial sheath resection-achieving R0 clearance via meticulous dissection along the anatomical plane between the adventitia and the external elastic lamina without sacrificing the underlying artery-has emerged as the preferred approach for managing arterial-involved LAPC.Based on this foundation,the arterial prophylactic occlusion technique(APOT)enhances the safety of sheath dissection through intraoperative temporary and graded flow control of the affected artery.APOT is indicated during arterial sheath dissection after neoadjuvant therapy;by providing graded temporary flow control,it can shorten operative time,reduce blood loss,achieve an R0 resection rate of 85.7%,and does not increase complications.

金钢;郑楷炼;经纬;时霄寒;高绥之;汪超

海军军医大学第一附属医院肝胆胰脾外科,上海 200433海军军医大学第一附属医院肝胆胰脾外科,上海 200433海军军医大学第一附属医院肝胆胰脾外科,上海 200433海军军医大学第一附属医院肝胆胰脾外科,上海 200433海军军医大学第一附属医院肝胆胰脾外科,上海 200433海军军医大学第一附属医院肝胆胰脾外科,上海 200433

医药卫生

局部进展期胰腺癌动脉鞘剥除技术动脉预阻断技术动脉切除重建新辅助治疗

locally advanced pancreatic cancerarterial sheath resectionarterial prophylactic occlusion techniquearterial resection and reconstructionneoadjuvant therapy

《中国实用外科杂志》 2026 (8)

1055-1058,1076,5

National Science and Technology Major Project for Prevention and Treatment of Cancer,Cardiovascu-lar,Respiratory,and Metabolic Diseases(No.2025ZD0552306)General Incubation Program of Basic Medical Research of Naval Medical University(No.2022MS013) 癌症、心脑血管、呼吸和代谢性疾病防治研究国家科技重大专项(No.2025ZD0552306)海军军医大学校级基础医学研究课题面上孵化项目(No.2022MS013)

10.19538/j.cjps.issn1005-2208.2026.08.09

评论